NEWS 03 JULY 2018

• USFDA NEWS

DRUG	COMPANY	NEWS
Aripiprazole lauroxil (ARISTADA INITIO)	Alkermes PLC	FDA Approves ARISTADA INITIO for the Initiation of ARISTADA for Schizophrenia
Milnacipran Hydrochloride	Strides Shasun	Strides Shasun receives USFDA Tentative Approval for Milnacipran Hydrochloride Tablets
Nifedipine ER Tablets & Cholestyramine for Oral Suspension	Zydus	Zydus receives final approval from the USFDA for Nifedipine Extended-Release Tablets USP and Cholestyramine for Oral Suspension USP
Colchicine	Par Pharmaceutical	Endo launches Authorized Generic Version of colchicines in the United States

 

 

·         NATCO launches fixed dose combination of Sofosbuvir-Daclatasvir drug for Hepatitis C treatment in INDIA

 

*For browsing official press releases click on the respective news item.